REVERSIBLE SUPPRESSION OF MENSTRUATION W/ ANTIPROGESTINS
REVERSIBLE SUPPRESSION OF MENSTRUATION W/ ANTIPROGESTINS
批准号:
6116134
负责人:
ROBERT M BRENNER
金额:
$9.03万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-15 至 2000-04-30
中文摘要
我们在这项研究中的目标是开发一种安全,可逆的方法,
抑制月经的药物,
抗孕激素 之前我们曾指出,短期系统性
用先灵抗胰蛋白酶ZK 137 316(ZK 316)治疗将
抑制月经。 我们现在进行了一项长期研究,
用ZK 316处理的骑自行车的恒河猴。 在这项研究中,所有
动物表现出正常的治疗前月经周期(平均值_ SE;
28.3_ 1.4天)。 注射ZK 316 0.05和0.1 mg/kg,持续100
天阻止月经,并显着延长
所有猴子的月经间期。 经间期
对照组、0.05组和0.1组的间期分别为28.1 ± 0.83、131.1 ± 0.84和131.1 ± 0.83。
10.1 134 ~ 8.7天(P < 0.001)。 在过去30
给药30天后,对照组猴表达正常
雌二醇(E2)和孕酮(P)的月经周期模式。 在
此外,0.05 mg/kg ZK 316格鲁组所有猴(n = 4)
卵泡期E2水平正常(包括E2激增),
正常黄体期P水平。在该组中,ZK 316抑制
月经,尽管在黄体期P结束时正常下降,
循环 然而,0.1 mg/kg组的所有猴子都失败了
出现正常的E2激增(E2水平升高至200 pg/ml以上),或
正常黄体期水平的P(>1 ng/ml)在过去30天的
治疗 尽管在这一组中有排卵阻滞,但所有的
猴子显示正常的非激增水平的E2水平(~30-100 pg/ml)。
所有ZK 316治疗的猴子在40天内恢复正常的周期性
治疗后周期长度均正常(29.8
_ 3.0天)。 未检测到治疗的不良反应,
猴子在研究中 总之,我们现在已经表明,
长期抗孕酮治疗将可逆地抑制月经
在恒河猴身上。 国防部分包合同
出版物Slayden OD,Chwalisz K,Vidgoff J,Brenner RM. 剂量
新一代抗白细胞介素ZK 137 - 316的相关作用
切除卵巢和骑自行车的恒河猴。 生物生殖学(增刊1)58:186,1998
(摘要365)。 Slayden OD,Zelinski-Wooten MB,Chwalisz K,Stouffer
RL,Brenner RM. 慢性治疗骑自行车的恒河猴低
剂量的抗白细胞介素ZK 137 316的形态学评估
子宫和输卵管。 Reprod 13:269-277,1998. Zelinski-Wooten MB,
Chwalisz K,Illiff SA,Niemeyer CL,Eaton GG,Loriaux DL,Slayden OD,
Brenner RM,Stouffer RL. 一种慢性、低剂量的
antiresistin ZK 137 316可预防恒河猴怀孕。 嗡嗡声
Reprod 13:2132-2138,1998。 Zelinski-Wooten MB,Slayden OD,Chwalisz
K,Hess DL,Brenner RM,Stouffer RL. 慢性治疗骑自行车
恒河猴与低剂量的抗白细胞介素ZK 137 316
建立允许正常月经周期的方案。
Reprod 13:259-267,1998.
英文摘要
Our goal in this research is to develop a safe, reversible method
of menstrual suppression with a class of compounds called
antiprogestins. Previously we showed that short-term systemic
treatment with the Schering antiprogestin ZK 137 316 (ZK316) will
suppress menstruation. We have now conducted a long-term study of
cycling rhesus monkeys treated with ZK316. In this study, all of the
animals exhibited normal pretreatment menstrual cycles (mean _ SE;
28.3 _ 1.4 days). Injection with ZK316 at 0.05 and 0.1 mg/kg for 100
days blocked menstruation and significantly extended the
intermenstrual interval in all of the monkeys. Intermenstrual
interval in the control, 0.05 and 0.1 groups were 28.1 _ 0.83, 131.1 _
10.1 and 134 _ 8.7 days, respectively (P < 0.001). During the last 30
days of treatment, the monkeys in the control group expressed normal
menstrual cycle patterns of estradiol (E2) and progesterone (P). In
addition, all of the monkeys in the 0.05 mg/kg ZK316 grou p (n = 4)
had normal follicular phase levels of E2 (including an E2 surge) and
normal luteal phase levels of P. In this group, ZK316 suppressed
menstruation despite a normal decline in luteal phase P at the end of
the cycle. However, all of the monkeys in the 0.1 mg/kg group failed
to develop a normal E2 surge (E2 levels rising above 200 pg/ml) or
normal luteal phase levels of P (>1 ng/ml) during the last 30 days of
treatment. Despite blockade of ovulation in this group, all of the
monkeys showed normal nonsurge levels of E2 levels (~30-100 pg/ml).
All ZK316-treated monkeys returned to normal cyclicity within 40 days
and posttreatment cycle lengths were normal in all of the groups (29.8
_ 3.0 days). No untoward effects of treatment were detected in the
monkeys during the study. In summary, we have now shown that
long-term antiprogestin treatment will reversibly inhibit menstruation
in rhesus monkeys. FUNDING Department of Defense Subcontract
PUBLICATIONS Slayden OD, Chwalisz K, Vidgoff J, Brenner RM. Dose
related effects of the new generation antiprogestin ZK 137 316 in
spayed and cycling rhesus macaques. Biol Reprod (Suppl 1) 58:186,1998
(abstract 365). Slayden OD, Zelinski-Wooten MB, Chwalisz K, Stouffer
RL, Brenner RM. Chronic treatment of cycling rhesus monkeys with low
doses of the antiprogestin ZK 137 316 Morphometric assessment of the
uterus and oviduct. Hum Reprod 13:269-277, 1998. Zelinski-Wooten MB,
Chwalisz K, Illiff SA, Niemeyer CL, Eaton GG, Loriaux DL, Slayden OD,
Brenner RM, Stouffer RL. A chronic, low dose regimen of the
antiprogestin ZK 137 316 prevents pregnancy in rhesus monkeys. Hum
Reprod 13:2132-2138, 1998. Zelinski-Wooten MB, Slayden OD, Chwalisz
K, Hess DL, Brenner RM, Stouffer RL. Chronic treatment of cycling
rhesus monkeys with low doses of the antiprogestin ZK 137 316
Establishment of a regimen that permits normal menstrual cyclicity.
Hum Reprod 13:259-267, 1998.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SUPPRESSION OF BREAKTHROUGH BLEEDING IN USERS OF PROGESTIN CONTRACEPTIVES
-
批准号:7165227
-
项目类别:
-
资助金额:$7.47万
-
财政年份:2005
-
负责人:ROBERT M BRENNER
-
依托单位:
ENDOMETRIAL CYCLES IN VERVET MONKEYS (CERCOPITHECUS AETHIOPS)
-
批准号:7165262
-
项目类别:
-
资助金额:$7.47万
-
财政年份:2005
-
负责人:ROBERT M BRENNER
-
依托单位:
HORMONAL CONTROL OF THE FEMALE REPRODUCTIVE TRACT
-
批准号:7165176
-
项目类别:
-
资助金额:$7.47万
-
财政年份:2005
-
负责人:ROBERT M BRENNER
-
依托单位:
SUPPRESSION OF BREAKTHROUGH BLEEDING IN USERS OF PROGESTIN CONTRACEPTIVES
-
批准号:6970675
-
项目类别:
-
资助金额:$8.22万
-
财政年份:2004
-
负责人:ROBERT M BRENNER
-
依托单位:
HORMONAL CONTROL OF THE FEMALE REPRODUCTIVE TRACT
-
批准号:6970601
-
项目类别:
-
资助金额:$8.22万
-
财政年份:2004
-
负责人:ROBERT M BRENNER
-
依托单位:
Suppression of Breakthrough Bleeding in LNG-IUS Users
-
批准号:6560852
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2002
-
负责人:ROBERT M BRENNER
-
依托单位:
REVERSIBLE SUPPRESSION OF MENSTRUATION W/ ANTIPROGESTINS
-
批准号:6592354
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:ROBERT M BRENNER
-
依托单位:
Suppression of Breakthrough Bleeding in LNG-IUS Users
-
批准号:6798318
-
项目类别:
-
资助金额:$30.46万
-
财政年份:2002
-
负责人:ROBERT M BRENNER
-
依托单位:
HORMONAL CONTROL OF FEMALE REPRODUCTIVE TRACT
-
批准号:6592355
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:ROBERT M BRENNER
-
依托单位:
ANTIPROLIFERAT EFFECT OF ZK 230 211 ON ENDOMETRIUM IN OVARIECTOM RHESUS MONKEYS
-
批准号:6592356
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:ROBERT M BRENNER
-
依托单位:
ENDOMETRIAL EFFECT OF ANTIPROGESTIN RELEAS INTRAUTER DEVICE IN NON HUMAN PRIMATE
-
批准号:6592353
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:ROBERT M BRENNER
-
依托单位:
Suppression of Breakthrough Bleeding in LNG-IUS Users
-
批准号:6667348
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2002
-
负责人:ROBERT M BRENNER
-
依托单位:
HORMONAL CONTROL OF FEMALE REPRODUCTIVE TRACT
-
批准号:6453731
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:ROBERT M BRENNER
-
依托单位:
REVERSIBLE SUPPRESSION OF MENSTRUATION W/ ANTIPROGESTINS
-
批准号:6453730
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:ROBERT M BRENNER
-
依托单位:
ANTIPROLIFERAT EFFECT OF ZK 230 211 ON ENDOMETRIUM IN OVARIECTOM RHESUS MONKEYS
-
批准号:6453732
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:ROBERT M BRENNER
-
依托单位:
ENDOMETRIAL EFFECT OF ANTIPROGESTIN RELEAS INTRAUTER DEVICE IN NON HUMAN PRIMATE
-
批准号:6453729
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:ROBERT M BRENNER
-
依托单位:
ANTIPROLIFERAT EFFECT OF ZK 230 211 ON ENDOMETRIUM IN OVARIECTOM RHESUS MONKEYS
-
批准号:6116136
-
项目类别:
-
资助金额:$9.03万
-
财政年份:1999
-
负责人:ROBERT M BRENNER
-
依托单位:
ENDOMETRIAL EFFECT OF ANTIPROGESTIN RELEAS INTRAUTER DEVICE IN NON HUMAN PRIMATE
-
批准号:6116133
-
项目类别:
-
资助金额:$9.03万
-
财政年份:1999
-
负责人:ROBERT M BRENNER
-
依托单位:
HORMONAL CONTROL OF FEMALE REPRODUCTIVE TRACT
-
批准号:6116135
-
项目类别:
-
资助金额:$9.03万
-
财政年份:1999
-
负责人:ROBERT M BRENNER
-
依托单位:
CORE--MORPHOLOGY
-
批准号:6258766
-
项目类别:
-
资助金额:$11.42万
-
财政年份:1998
-
负责人:ROBERT M BRENNER
-
依托单位:
海外基金